P145 Circulating interferon-α levels are elevated during pregnancy in women with SLE who deliver infants that are small for gestational age, preterm and/or have low birth weight

P145 Circulating interferon-α levels are elevated during pregnancy in women with SLE who deliver infants that are small for gestational age, preterm and/or have low birth weight

Bibliographic Details
Main Authors:	Henrik Zetterberg, Kaj Blennow, Elisabet Svenungsson, Iva Gunnarsson, Agneta Zickert, Lars Rönnblom, Andreas Jönsen, Christopher Sjöwall, Dag Leonard, Anders A Bengtsson, Estelle Trysberg, Muna Saleh, Anna Rudin, Marit Stockfelt, Helena Strevens, Bo Jacobsson, Anna-Carin Lundell, Agnes Torell, Tansim Akhter, Sofia Pihl, Maria Majcuk Sennström
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-03-01
Series:	Lupus Science and Medicine

Similar Items

P146 Low CD4+ T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy
by: Henrik Zetterberg, et al.
Published: (2024-03-01)

Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy
by: Agnes Torell, et al.
Published: (2024-03-01)

Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus
by: Agnes Torell, et al.
Published: (2023-06-01)

PO.8.176 Inflammation in blood and placenta in SLE pregnancies
by: M Saleh, et al.
Published: (2022-10-01)

Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies
by: Henrik Zetterberg, et al.
Published: (2021-05-01)

Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis.
by: Karin Bolin, et al.
Published: (2013-01-01)

PO.1.20 Prognostic biomarkers of organ damage in patients with newly diagnosed SLE
by: D Leonard, et al.
Published: (2022-10-01)

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus
by: Azita Sohrabian, et al.
Published: (2019-11-01)

O10 Ischemic stroke subtypes in SLE-associations with a STAT4 risk genotype
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

P58 Menopausal age and the effect of menopause on disease activity in SLE
by: Aleksandra Antovic, et al.
Published: (2024-03-01)

O34 Plasma thrombospondin-1 levels are associated with arterial and venous thrombotic events in systemic lupus erythematosus
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity
by: Susanne Pettersson, et al.
Published: (2021-04-01)

O12 Immune complexes containing anti-dsDNA in patients with systemic lupus erythematosus with renal involvement – Association with renal activity and response to treatment
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
by: Vilija Oke, et al.
Published: (2017-06-01)

Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis
by: Anders Larsson, et al.
Published: (2022-07-01)

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus
by: Vilija Oke, et al.
Published: (2019-04-01)

Sex differences in clinical presentation of systemic lupus erythematosus
by: Jorge I. Ramírez Sepúlveda, et al.
Published: (2019-12-01)

Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA‐DRB1 Genotype Associations and Immunological and Clinical Manifestations
by: Lina‐Marcela Diaz‐Gallo, et al.
Published: (2022-01-01)

Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients
by: Myriam Martin, et al.
Published: (2020-10-01)

Neutrophil gelatinase-associated lipocalin (NGAL) in lupus nephritis and beyond
by: Elisabet Svenungsson, et al.
Published: (2025-01-01)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
by: Henrik Zetterberg, et al.
Published: (2021-02-01)

Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis—a spin-off study of the NORD-STAR randomized clinical trial
by: Marit Stockfelt, et al.
Published: (2021-07-01)

O4 Clinical characteristics of patients with high SLE-specific and high multitrait polygenic risk – An investigation of SLE risk loci
by: Lars Rönnblom, et al.
Published: (2024-03-01)

P77 Identification of a cluster of SLE risk loci associated with levels of multiple blood biomarkers in the general population – Implication for SLE sub-phenotypes
by: Lars Rönnblom, et al.
Published: (2024-03-01)

Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study
by: Tomas Walhelm, et al.
Published: (2021-10-01)

Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers
by: Kristīne Ivanova, et al.
Published: (2024-08-01)

Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy.
by: Ulrika Andersson-Hall, et al.
Published: (2021-01-01)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
by: Ulf Andreasson, et al.
Published: (2016-01-01)

Novel risk genes for systemic lupus erythematosus predicted by random forest classification
by: Jonas Carlsson Almlöf, et al.
Published: (2017-07-01)

Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
by: Marie Eckerström, et al.
Published: (2020-12-01)

PO.5.110 Plasma levels of osteopontin in SLE
by: M Compagno, et al.
Published: (2022-10-01)

Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis
by: Igal Rosenstein, et al.
Published: (2022-08-01)

High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
by: Igal Rosenstein, et al.
Published: (2023-01-01)

S12.1 Il-16 – a urinary biomarker for proliferative lupus nephritis
by: V Oke, et al.
Published: (2022-10-01)

S13.2 Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with hHLA-DRB1 *13 and negatively with HLA-DRB1*03 in SLE
by: J Rönnelid, et al.
Published: (2022-10-01)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
by: Nicholas J. Ashton, et al.
Published: (2021-06-01)

PO.4.94 High B-cell polygenic risk is associated with dsDNA antibodies and nephritis in systemic lupus erythematosus
by: S Reid, et al.
Published: (2022-10-01)

Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor–induced CNS inflammationResearch in context
by: Sara Bjursten, et al.
Published: (2024-02-01)

Adipocytokines in Untreated Newly Diagnosed Rheumatoid Arthritis: Association with Circulating Chemokines and Markers of Inflammation
by: Georgios K. Vasileiadis, et al.
Published: (2021-02-01)

B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical Practice
by: Ioannis Parodis, et al.
Published: (2020-07-01)